Department of Emergency Medicine, American University of Beirut, Lebanon.
Intensive Care Department, Ministry of National Guard Health Affairs, King Abdullah International Medical Research Center, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia.
Medicine (Baltimore). 2021 Nov 19;100(46):e27593. doi: 10.1097/MD.0000000000027593.
The aim of this study is to examine the outcome of septic patients with cirrhosis admitted to the intensive care unit (ICU) and predictors of mortality.Single center, retrospective cohort study.The study was conducted in Intensive care Department of King Abdulaziz Medical City, Riyadh, Saudi Arabia.Data was extracted from a prospectively collected ICU database managed by a full time data collector. All patients with an admission diagnosis of sepsis according to the sepsis-3 definition were included from 2002 to 2017. Patients were categorized into 2 groups based on the presence or absence of cirrhosis.The primary outcome of the study was in-hospital mortality. Secondary outcomes included ICU mortality, ICU and hospital lengths of stay and mechanical ventilation duration.A total of 7906 patients were admitted to the ICU with sepsis during the study period, of whom 497 (6.29%) patients had cirrhosis. 64.78% of cirrhotic patients died during their hospital stay compared to 31.54% of non-cirrhotic. On multivariate analysis, cirrhosis patients were at greater odds of dying within their hospital stay as compared to non-cirrhosis patients (Odds ratio {OR} 2.53; 95% confidence interval {CI} 2.04 - 3.15) independent of co-morbidities, organ dysfunction or hemodynamic status. Among cirrhosis patients, elevated international normalization ratio (INR) (OR 1.69; 95% CI 1.29-2.23), hemodialysis (OR 3.09; 95% CI 1.76-5.42) and mechanical ventilation (OR 2.61; 95% CI 1.60-4.28) were the independent predictors of mortality.Septic cirrhosis patients admitted to the intensive care unit have greater odds of dying during their hospital stay. Among septic cirrhosis patients, elevated INR and the need for hemodialysis and mechanical ventilation were associated with increased mortality.
本研究旨在探讨入住重症监护病房(ICU)的肝硬化脓毒症患者的预后及死亡预测因素。
单中心回顾性队列研究。该研究在沙特阿拉伯利雅得阿卜杜勒阿齐兹国王医疗城的重症监护病房进行。数据取自由全职数据收集员管理的前瞻性收集的 ICU 数据库。所有符合脓毒症-3 定义的脓毒症入院诊断的患者均于 2002 年至 2017 年期间被纳入研究。根据是否存在肝硬化将患者分为两组。本研究的主要转归为院内死亡率。次要转归包括 ICU 死亡率、ICU 和住院时间及机械通气时间。
在研究期间,共有 7906 名患者因脓毒症入住 ICU,其中 497 名(6.29%)患者患有肝硬化。住院期间,肝硬化患者中有 64.78%死亡,而非肝硬化患者中有 31.54%死亡。多变量分析显示,与非肝硬化患者相比,肝硬化患者在住院期间死亡的可能性更大(比值比 {OR} 2.53;95%置信区间 {CI} 2.04-3.15),与合并症、器官功能障碍或血流动力学状态无关。在肝硬化患者中,国际标准化比值(INR)升高(OR 1.69;95% CI 1.29-2.23)、血液透析(OR 3.09;95% CI 1.76-5.42)和机械通气(OR 2.61;95% CI 1.60-4.28)是死亡的独立预测因素。
入住 ICU 的脓毒症肝硬化患者在住院期间死亡的可能性更大。在脓毒症肝硬化患者中,INR 升高以及需要血液透析和机械通气与死亡率增加相关。